Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).

Rocco MV, Sink KM, Lovato LC, Wolfgram DF, Wiegmann TB, Wall BM, Umanath K, Rahbari-Oskoui F, Porter AC, Pisoni R, Lewis CE, Lewis JB, Lash JP, Katz LA, Hawfield AT, Haley WE, Freedman BI, Dwyer JP, Drawz PE, Dobre M, Cheung AK, Campbell RC, Bhatt U, Beddhu S, Kimmel PL, Reboussin DM, Chertow GM; SPRINT Research Group.

Am J Kidney Dis. 2018 Mar;71(3):352-361. doi: 10.1053/j.ajkd.2017.08.021. Epub 2017 Nov 20.

2.

Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?

Margolis KL, Davis BR, Baimbridge C, Ciocon JO, Cuyjet AB, Dart RA, Einhorn PT, Ford CE, Gordon D, Hartney TJ, Julian Haywood L, Holtzman J, Mathis DE, Oparil S, Probstfield JL, Simpson LM, Stokes JD, Wiegmann TB, Williamson JD.

J Clin Hypertens (Greenwich). 2013 Dec;15(12):941. doi: 10.1111/jch.12220. Epub 2013 Oct 30. No abstract available.

3.

Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Margolis KL, Davis BR, Baimbridge C, Ciocon JO, Cuyjet AB, Dart RA, Einhorn PT, Ford CE, Gordon D, Hartney TJ, Julian Haywood L, Holtzman J, Mathis DE, Oparil S, Probstfield JL, Simpson LM, Stokes JD, Wiegmann TB, Williamson JD; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2013 Aug;15(8):542-54. doi: 10.1111/jch.12139. Epub 2013 Jun 10.

4.

Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy.

Packham DK, Wolfe R, Reutens AT, Berl T, Heerspink HL, Rohde R, Ivory S, Lewis J, Raz I, Wiegmann TB, Chan JC, de Zeeuw D, Lewis EJ, Atkins RC; Collaborative Study Group.

J Am Soc Nephrol. 2012 Jan;23(1):123-30. doi: 10.1681/ASN.2011040378. Epub 2011 Oct 27.

5.

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.

Heerspink HL, Greene T, Lewis JB, Raz I, Rohde RD, Hunsicker LG, Schwartz SL, Aronoff S, Katz MA, Eisner GM, Mersey JH, Wiegmann TB; Collaborative Study Group.

Nephrol Dial Transplant. 2008 Jun;23(6):1946-54. Epub 2007 Dec 18.

PMID:
18089623
6.

Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.

Sharma R, Sharma M, Reddy S, Savin VJ, Nagaria AM, Wiegmann TB.

Front Biosci. 2006 Jan 1;11:968-76. Review.

PMID:
16146787
7.

Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial.

Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Pohl M, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ; Collaborative Study Group.

J Am Soc Nephrol. 2005 Jul;16(7):2170-9. Epub 2005 Jun 1.

8.

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy.

Atkins RC, Briganti EM, Lewis JB, Hunsicker LG, Braden G, Champion de Crespigny PJ, DeFerrari G, Drury P, Locatelli F, Wiegmann TB, Lewis EJ.

Am J Kidney Dis. 2005 Feb;45(2):281-7.

PMID:
15685505
9.

Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial.

Hunsicker LG, Atkins RC, Lewis JB, Braden G, de Crespigny PJ, DeFerrari G, Drury P, Locatelli F, Wiegmann TB, Lewis EJ; Collaborative Study Group.

Kidney Int Suppl. 2004 Nov;(92):S99-101. Review.

10.

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.

Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Parikh CR, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ; Irbesartan Diabetic Nephropathy Trial. Collaborative Study Group.

Ann Intern Med. 2003 Apr 1;138(7):542-9.

PMID:
12667024
12.

Both subtype 1 and 2 receptors of angiotensin II participate in regulation of intracellular calcium in glomerular epithelial cells.

Sharma R, Sharma M, Vamos S, Savin VJ, Wiegmann TB.

J Lab Clin Med. 2001 Jul;138(1):40-9.

PMID:
11433227
13.

Renal structural-functional relationships in early diabetes mellitus.

Ellis EN, Warady BA, Wood EG, Hassanein R, Richardson WP, Lane PH, Howard C, Kemp SF, Aceto T, Garibaldi L, Wiegmann TB, Savin VJ.

Pediatr Nephrol. 1997 Oct;11(5):584-91.

PMID:
9323284
15.

Simultaneous imaging of intracellular [Ca2+] and pH in single cells.

Wiegmann TB, Vamos S, Welling LW, Beatty DM, Morris SJ.

Int Rev Exp Pathol. 1996;36:175-96. No abstract available.

PMID:
8860942
16.

Maintenance of bradykinin-induced intracellular calcium response of MDCK cells depends on extracellular calcium.

Vamos S, Welling LW, Wiegmann TB.

J Lab Clin Med. 1995 Apr;125(4):470-8. Erratum in: J Lab Clin Med 1995 Oct;126(4):329.

PMID:
7706902
17.

Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.

Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica DA, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA, et al.

Kidney Int Suppl. 1994 Feb;45:S150-5.

PMID:
8158885
18.

Rapid simultaneous estimation of intracellular calcium and pH.

Morris SJ, Wiegmann TB, Welling LW, Chronwall BM.

Methods Cell Biol. 1994;40:183-220. Review. No abstract available.

PMID:
8201976
19.

Simultaneous imaging of intracellular [Ca2+] and pH in single MDCK and glomerular epithelial cells.

Wiegmann TB, Welling LW, Beatty DM, Howard DE, Vamos S, Morris SJ.

Am J Physiol. 1993 Oct;265(4 Pt 1):C1184-90.

PMID:
8238309
20.

Calcium regulation of intracellular pH in pituitary intermediate lobe melanotropes.

Beatty DM, Chronwall BM, Howard DE, Wiegmann TB, Morris SJ.

Endocrinology. 1993 Sep;133(3):972-84.

PMID:
8396024
21.

Vasoactive substances induce cytoskeletal changes in cultured rat glomerular epithelial cells.

Sharma R, Lovell HB, Wiegmann TB, Savin VJ.

J Am Soc Nephrol. 1992 Nov;3(5):1131-8.

22.
23.

Ambulatory blood pressure in type I diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults.

Moore WV, Donaldson DL, Chonko AM, Ideus P, Wiegmann TB.

Diabetes. 1992 Sep;41(9):1035-41.

PMID:
1499855
24.

The role of disease duration and hypertension in albumin excretion of type I diabetes mellitus.

Wiegmann TB, Chonko AM, MacDougall ML, Moore WV.

J Am Soc Nephrol. 1992 May;2(11):1587-92.

25.

Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients.

Wiegmann TB, Herron KG, Chonko AM, MacDougall ML, Moore WV.

Diabetes. 1992 Jan;41(1):62-7.

PMID:
1727741
26.

Single-dose subcutaneous iodine-131-iodohippurate for determination of renal plasma flow.

Grant ME, Herron KG, MacDougall ML, Preston DF, Moore WV, Wiegmann TB.

J Nucl Med. 1991 Jul;32(7):1452-4.

27.

Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recordings in type I diabetes mellitus.

Wiegmann TB, Herron KG, Chonko AM, MacDougall ML, Moore WV.

Diabetes. 1990 Dec;39(12):1556-60.

PMID:
2245880
28.

Prediction of carcinoma in acquired cystic disease as a function of kidney weight.

MacDougall ML, Welling LW, Wiegmann TB.

J Am Soc Nephrol. 1990 Nov;1(5):828-31.

29.

Comparison of albumin excretion rate obtained with different times of collection.

Wiegmann TB, Chonko AM, Barnard MJ, MacDougall ML, Folscroft J, Stephenson J, Kyner JL, Moore WV.

Diabetes Care. 1990 Aug;13(8):864-71.

PMID:
2209321
30.
31.

Principles, uses, and complications of hemodialysis.

Jameson MD, Wiegmann TB.

Med Clin North Am. 1990 Jul;74(4):945-60. Review.

PMID:
2195264
32.

Glomerular effects of angiotensin II require intrarenal factors.

Wiegmann TB, MacDougall ML, Savin VJ.

Am J Physiol. 1990 Mar;258(3 Pt 2):F717-21.

PMID:
2316674
33.

In vitro effects of cyclosporine on glomerular function.

Wiegmann TB, Sharma R, Diederich DA, Savin VJ.

Am J Med Sci. 1990 Mar;299(3):149-52.

PMID:
2316558
34.

Controlled changes in chronic dietary protein intake do not change glomerular filtration rate.

Wiegmann TB, Zlomke AM, MacDougall ML, Kipp DE.

Am J Kidney Dis. 1990 Feb;15(2):147-54.

PMID:
2301386
35.

Urate excretion by the isolated perfused rat kidney and modification by drugs.

MacDougall ML, Wiegmann TB.

Proc Soc Exp Biol Med. 1989 Dec;192(3):276-80.

PMID:
2602393
36.

The effect of water loading on albumin excretion in type I diabetes mellitus.

Wiegmann TB, Chonko AM, Herron K, MacDougall ML, Moore WV.

J Diabet Complications. 1989 Oct-Dec;3(4):187-90.

PMID:
2533209
37.

Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.

Wiegmann TB, MacDougall ML, Diederich DA.

Am J Kidney Dis. 1988 May;11(5):418-24.

PMID:
3259402
38.
39.

Long-term comparisons of citrate and heparin as anticoagulants for hemodialysis.

Wiegmann TB, MacDougall ML, Diederich DA.

Am J Kidney Dis. 1987 May;9(5):430-5.

PMID:
3107378
40.

Renal adenocarcinoma and acquired cystic disease in chronic hemodialysis patients.

MacDougall ML, Welling LW, Wiegmann TB.

Am J Kidney Dis. 1987 Feb;9(2):166-71.

PMID:
3826064
41.

Arachnoid cyst in a patient with autosomal-dominant polycystic kidney disease.

Allen A, Wiegmann TB, MacDougall ML.

Am J Kidney Dis. 1986 Aug;8(2):128-30.

PMID:
3740061
42.
43.

Percutaneous transluminal angioplasty in transplant renal artery stenosis: experience and review of the literature.

Lohr JW, MacDougall ML, Chonko AM, Diederich DA, Grantham JJ, Savin VJ, Wiegmann TB.

Am J Kidney Dis. 1986 May;7(5):363-7. Review.

PMID:
2939712
44.

Microscopic hematuria.

Brown SH, MacDougall ML, Wiegmann TB.

Kans Med. 1986 Apr;87(4):99-101, 113. No abstract available.

PMID:
3712913
45.

Effective use of streptokinase for peritoneal catheter failure.

Wiegmann TB, Stuewe B, Duncan KA, Chonko A, Diederich DA, Grantham JJ, Savin VJ, MacDougall ML.

Am J Kidney Dis. 1985 Aug;6(2):119-23.

PMID:
4025331
46.

Legionnaires' disease associated with rash and renal failure.

Allen TP, Fried JS, Wiegmann TB, Hodges GR, Dixon AY, Lee SH, MacDougall ML.

Arch Intern Med. 1985 Apr;145(4):729-30.

PMID:
3985734
47.

PCP intoxication. Management of associated renal failure.

Artzer D, Patak RV, Wiegmann TB.

J Kans Med Soc. 1983 Jul;84(7):384-5, 422. No abstract available.

PMID:
6886514
48.

The dilemmas of patient treatment for end-stage renal disease.

Schmidt RW, Blumenkrantz M, Wiegmann TB.

Am J Kidney Dis. 1983 Jul;3(1):37-47.

PMID:
6346866
49.

Home dialysis and dialysis treatment modalities in the VA system.

Wiegmann TB, Blumenkrantz M, Layard M, Schmidt RW, Shen F, Stead W.

Am J Kidney Dis. 1983 Jul;3(1):32-6.

PMID:
6346865
50.

Acute polyuric renal failure after aspirin intoxication.

Rupp DJ, Seaton RD, Wiegmann TB.

Arch Intern Med. 1983 Jun;143(6):1237-8.

PMID:
6860051

Supplemental Content

Loading ...
Support Center